BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9881 related articles for article (PubMed ID: 10953359)

  • 1. Analysis of the DNA content in the progression of recurrent and metastatic melanomas.
    Korabiowska M; Brinck U; Kotthaus I; Berger H; Droese M
    Anticancer Res; 2000; 20(4):2791-4. PubMed ID: 10953359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin expression correlates with aneuploidy in cytological specimens of melanoma metastases.
    Korabiowska M; Ruschenburg I; Schulz H; Steinacker A; Bortkiewicz P; Sevenich M; Brinck U; Cordon-Cardo C; Fischer G
    Anticancer Res; 2005; 25(4):2789-92. PubMed ID: 16080528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of newly defined ploidy related parameters in melanoma.
    Korabiowska M; Brinck U; Brinkmann U; Berger H; Ruschenburg I; Droese M
    Anticancer Res; 2000; 20(3A):1685-90. PubMed ID: 10928092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of new ploidy-related parameters for the diagnosis of ovarian tumours.
    Korabiowska M; Brinck U; Skubis J; Sattler B; Fischer G
    Anticancer Res; 2004; 24(6):4191-4. PubMed ID: 15736472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of DNA ploidy status and DNA ploidy-related parameters in malignant melanoma tissue microarrays and full sections.
    Korabiowska M; Cordon-Cardo C; Buschmann N; Stachura J; Fischer G; Brinck U
    Hum Pathol; 2004 Jul; 35(7):887-91. PubMed ID: 15257554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
    Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
    Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
    Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
    Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear DNA profiles in primary melanomas and their metastases.
    Rode J; Williams RA; Charlton IG; Dhillon AP; Moss E
    Cancer; 1991 May; 67(9):2333-6. PubMed ID: 2013040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytofluorometric DNA analyses of metastases of human malignant melanomas.
    Hansson J; Tribukait B; Lewensohn R; Ringborg U
    Anal Quant Cytol; 1982 Jun; 4(2):99-104. PubMed ID: 7114625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ploidy status of melanoma metastases in different locations.
    Korabiowska M; Ruschenburg I; Brinck U; Jahns A; Berger H; Droese M
    Int J Mol Med; 1998 Jul; 2(1):113-6. PubMed ID: 9854154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA-ploidy and proliferation in metastatic neuroblastoma].
    Böhm N; Lampert F
    Klin Padiatr; 1982; 194(4):270-4. PubMed ID: 7132228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of ploidy related parameters for prognosis in malignant fibrous histiocytomas.
    Brinck U; Korabiowska M; Buschmann N; Stachura J; Ruschenburg I; Cordon-Cardo C; Schauer A
    Anticancer Res; 1999; 19(6B):5211-6. PubMed ID: 10697537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease.
    Karlsson M; Boeryd B; Carstensen J; Kågedal B; Bratel AT; Wingren S
    Br J Cancer; 1993 Jan; 67(1):134-8. PubMed ID: 8427773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant potential of aneuploid pancreatic endocrine tumours.
    Lee CS; Charlton IG; Williams RA; Dhillon AP; Rode J
    J Pathol; 1993 Apr; 169(4):451-6. PubMed ID: 8501543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy of malignant melanoma determined by image cytometry of fresh frozen and paraffin-embedded tissue.
    Herzberg AJ; Kerns BJ; Borowitz MJ; Seigler HF; Kinney RB
    J Cutan Pathol; 1991 Dec; 18(6):440-8. PubMed ID: 1774354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-ploidy abnormalities are a reflection of the metastatic potential of malignant melanoma. Microfluorometric DNA analysis.
    Umebayashi Y; Otsuka F
    Acta Derm Venereol; 1997 Mar; 77(2):118-21. PubMed ID: 9111821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-index and stereological estimation of nuclear volume in primary and metastatic malignant melanomas: a comparative study with analysis of heterogeneity.
    Sørensen FB; Kristensen IB; Grymer F; Jakobsen A
    APMIS; 1990 Jan; 98(1):61-70. PubMed ID: 2302343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions.
    Kuźbicki L; Gajo B; Chwirot BW
    Melanoma Res; 2006 Jun; 16(3):235-43. PubMed ID: 16718270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 495.